FOXO3 induces ubiquitylation of AKT through MUL1 regulation

Sun-Yong Kim1, Hyo Jeong Kim1,2, Hyung Kwon Byeon3,4

  • 1Department of Otolaryngology, Ajou University School of Medicine, Suwon, Republic of Korea.

Oncotarget
|January 5, 2018
PubMed

Insights

Cisplatin triggers thyroid cancer cell death by activating the mitochondrial E3 ubiquitin ligase 1 (MUL1) and inhibiting AKT. This pathway, involving FOXO3 and reactive oxygen species (ROS), offers a new strategy for head and neck cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • AKT (protein kinase B) is crucial for cell survival and tumor progression, making it a key target in cancer therapy.
  • Mitochondrial E3 ubiquitin protein ligase 1 (MUL1) is downregulated in head and neck cancer (HNC) and negatively regulates AKT.
  • Mechanisms controlling MUL1 function are not fully understood.

Purpose of the Study:

  • To investigate the role of the MUL1-AKT axis in cisplatin-induced thyroid cancer cell death.
  • To elucidate the regulatory mechanisms of MUL1, particularly the involvement of FOXO3 and reactive oxygen species (ROS).
  • To explore the potential of targeting the FOXO3-MUL1-AKT pathway for HNC treatment.

Main Methods:

  • Investigated cisplatin (CDDP) effects on thyroid cancer cells.
  • Analyzed the ubiquitylation of active AKT mediated by MUL1.
  • Examined the role of forkhead box O3 (FOXO3) and intracellular ROS in the CDDP-induced pathway.

Main Results:

  • CDDP treatment increases MUL1 expression, leading to ubiquitylation and inactivation of active AKT.
  • FOXO3 is essential for CDDP-induced MUL1 regulation; FOXO3 knockdown confers resistance to CDDP.
  • CDDP-induced intracellular ROS increment is a critical component of the FOXO3-MUL1-AKT signaling pathway.

Conclusions:

  • CDDP induces thyroid cancer cell death via the FOXO3-MUL1-AKT axis.
  • FOXO3 acts as a key regulator in this pathway, mediating MUL1's tumor-suppressive function.
  • Targeting the FOXO3-MUL1-AKT pathway presents a potential novel therapeutic strategy for HNC treatment with CDDP.

Related Concept Videos

GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.9K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K